| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
4D Molecular Therapeutics Inc (NASDAQ: FDMT)
FDMT Technical Analysis
5
| As on 9th Jun 2023 FDMT STOCK Price closed @ 21.97 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 11.77 & Strong Buy for SHORT-TERM with Stoploss of 16.92 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FDMTSTOCK Price
| Open | 19.52 | Change | Price | % |
| High | 22.24 | 1 Day | 2.45 | 12.55 |
| Low | 19.45 | 1 Week | 4.36 | 24.76 |
| Close | 21.97 | 1 Month | 0.95 | 4.52 |
| Volume | 609087 | 1 Year | 2.24 | 11.35 |
| 52 Week High 25.46 | 52 Week Low 5.68 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FDMT Daily Charts |
FDMT Intraday Charts |
Whats New @ Bazaartrend |
FDMT Free Analysis |
|
|
FDMT Important Levels Intraday
| RESISTANCE | 27.35 |
| RESISTANCE | 25.62 |
| RESISTANCE | 24.56 |
| RESISTANCE | 23.49 |
| SUPPORT | 20.45 |
| SUPPORT | 19.38 |
| SUPPORT | 18.32 |
| SUPPORT | 16.59 |
FDMT Forecast April 2024
| 4th UP Forecast | 36.87 |
| 3rd UP Forecast | 32.09 |
| 2nd UP Forecast | 29.14 |
| 1st UP Forecast | 26.18 |
| 1st DOWN Forecast | 17.76 |
| 2nd DOWN Forecast | 14.8 |
| 3rd DOWN Forecast | 11.85 |
| 4th DOWN Forecast | 7.07 |
FDMT Weekly Forecast
| 4th UP Forecast | 27.58 |
| 3rd UP Forecast | 25.78 |
| 2nd UP Forecast | 24.67 |
| 1st UP Forecast | 23.56 |
| 1st DOWN Forecast | 20.38 |
| 2nd DOWN Forecast | 19.27 |
| 3rd DOWN Forecast | 18.16 |
| 4th DOWN Forecast | 16.36 |
FDMT Forecast2024
| 4th UP Forecast | 62.76 |
| 3rd UP Forecast | 49.68 |
| 2nd UP Forecast | 41.59 |
| 1st UP Forecast | 33.51 |
| 1st DOWN Forecast | 10.43 |
| 2nd DOWN Forecast | 2.35 |
| 3rd DOWN Forecast | -5.74 |
| 4th DOWN Forecast | -18.82 |
4D Molecular Therapeutics Inc ( NASDAQ USA Symbol : FDMT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FDMT Business Profile
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; Benitec; CRF; Roche; CFF; and AstraZeneca. The company was founded in 2013 and is headquartered in Emeryville, California. Address: 5858 Horton Street, EmeryVille, CA, United States, 94608
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service